SNGX Conference

Soligenix Invited to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Published September 02, 2025 at 11:30 AM

(NASDAQ:SNGX) PRINCETON, N.J., Sept. 2, 2025 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that Christopher...